Table II.
Clinicopathological characteristics of cases of pleomorphic infiltrative lobular carcinomas (PILC) of the male breast previously described in the literature, and of the present case.
| Maly et al. | Rohini et al. | Ishida et al. | Zahir et al. | Murzabdillaeva et al. first case | Murzabdillaeva et al. second case | Saggini et al. | Costa et al. | Present case | |
|---|---|---|---|---|---|---|---|---|---|
| Year of report | 2005 | 2010 | 2013 | 2013 | 2017 | 2017 | 2020 | 2022 | 2023 |
| Age | 44 | 55 | 76 | 68 | 63 | 79 | 80 | 73 | 46 |
| Presentation | 2.5 cm mass | 4 cm mass | 3 cm mass | 2.8 cm mass | Left neck mass, 1.7 cm breast mass with nipple retraction and skin rash | 2 cm mass and skin itchiness | 3 cm erythematous plaque of the nipple | 3.9 cm mass, nipple retraction and skin thickening | 4 cm mass |
| Genetic mutations | Not evaluated | Not evaluated | Not evaluated | Not evaluated | Not evaluated | Negative for genetic testing | Not evaluated | BRCA2 mutation | PALB2 germline mutation c.1240C>T p.(Arg414*) |
| Risk factor | Grandmothers died of breast cancer | No risk factors | Gynecomastia Progestational agent for prostatic carcinoma for 10 years | Gynecomastia, alcohol abuse | Gynecomastia | No risk factors | Not reported | Obesity, treatment with finasteride for benign prostatic hyperplasia, family history of breast cancer (two nieces) | Mother with breast cancer |
| Estrogen Receptor | Positive | Not evaluated | Positive | Positive | Negative | Positive | Positive | Positive | Positive |
| Progesterone Receptor | Positive | Not evaluated | Negative | Positive | Negative | Positive | Positive | Positive | Positive |
| Her2/neu | Negative | Not evaluated | Negative | Negative | Negative | Negative | Negative | Negative | Negative and not amplified |
| E-Cadherin | Negative | Negative | Negative | Negative | Negative | Negative | Negative | Negative | Negative |
| Lymph node involvement | None | None | None | pN2a | pN3c | None | Not reported | pN1(sn) | pN0(i+)(sn) |
| Treatment | Radical mastectomy with axillary dissection | Radical mastectomy with axillary dissection | Not reported | 4 cycles of chemotherapy | 7 cycles of chemotherapy, radiotherapy | Left simple mastectomy with sentinel lymph node biopsy | Not reported | Left simple mastectomy with nipple excision and sentinel lymph node biopsy, chemotherapy, radiotherapy | Left simple mastectomy with sentinel lymph node biopsy, chemotherapy and radiotherapy |
| Follow-up | Disease free at 2 years | Disease free at 1 year | Disease free at 2 months | Disease free at 3.5 months | Brain metastasis | Disease free | Not reported | Not reported | Disease free at 1 year |